Ethics And AIDS Drugs

Some countries want to suspend patent and trade laws to get lower-cost medications to the poor

The latest drug cocktails may soon downgrade AIDS from a death sentence to a chronic disease--in countries that can afford the typical $15,000 annual cost per patient. But what about the cash-starved developing world, which currently accounts for nearly 90% of new HIV infections? It's an issue that countries like South Africa and Thailand are struggling with. And a growing number of government health ministers and AIDS activists are proposing an unusual solution: rip off the drug companies.

They're not really stealing, of course, but that's the way U.S. drug companies--backed by Uncle Sam--view a tactic being employed in South Africa...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!